Wall Street analysts expect that Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) will announce earnings per share (EPS) of ($0.50) for the current quarter, according to Zacks. Zero analysts have issued estimates for Zynerba Pharmaceuticals’ earnings. The highest EPS estimate is ($0.48) and the lowest is ($0.53). Zynerba Pharmaceuticals posted earnings of ($0.47) per share during the same quarter last year, which would suggest a negative year over year growth rate of 6.4%. The company is expected to announce its next quarterly earnings results on Thursday, November 14th.
On average, analysts expect that Zynerba Pharmaceuticals will report full-year earnings of ($2.02) per share for the current year, with EPS estimates ranging from ($2.11) to ($1.89). For the next financial year, analysts expect that the company will post earnings of ($2.02) per share, with EPS estimates ranging from ($2.35) to ($1.76). Zacks’ earnings per share calculations are a mean